Harvard Bioscience
HBIO
HBIO
70 hedge funds and large institutions have $60.6M invested in Harvard Bioscience in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
80% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 15
Holders
70
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.33M | |
| 2 | +$561K | |
| 3 | +$313K | |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$272K |
| 5 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$259K |
Top Sellers
| 1 | -$1.61M | |
| 2 | -$783K | |
| 3 | -$447K | |
| 4 |
Millennium Management
New York
|
-$422K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$359K |